PUBLIC COMPANY
savePromontory Therapeutics Inc
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
- phase2A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab
🐶 Hiring Signal
News
- New biotech alliance tells Congress to fight for US dominanceThe American Biotech Innovation Alliance took to Capitol Hill this week to tell members of Congress that the fight for US dominance in biopharma needs special attention. The alliance, created in Ma…endpoints · 3d ago
comments(0)
5-min edit window · permanent after that